Kevin Tracey

Feinstein researchers nab major NIH awards

Two cutting-edge Feinstein Institute for Medical Research projects have been selected for an elite National Institutes of Health funding program. Kevin Tracey, the institute’s president and CEO, and Ping Wang, Feinstein’s chief scientific officer, will continue their groundbreaking research into bioelectronic medicine and sepsis, respectively, with help from the NIH’s Maximizing Investigators’ Research Awards program. Through the NIH’s National Institute of General Medical Sciences – which supports “basic research that increases understanding of biological processes…


Study is big news for Vagus pioneer Tracey

By GREGORY ZELLER // Medical science has taken an enormous step toward “using electronics to replace drugs.” Kevin Tracey’s words sound downright science-fictional. And no, researchers cannot wave a medical tricorder and instantly cure ailments like “Star Trek” medic “Bones” McCoy. But they’re getting closer to a world where high-tech implants – not pharmaceuticals – are the most effective treatments for inflammatory diseases like rheumatoid arthritis and Parkinson’s disease. A recent clinical trial in the…


Feinstein’s Tracey to head bioelectronics summit

Feinstein Institute chief and global bioelectronics pioneer Kevin Tracey will headline a September New York Academy of Science conference on bioelectronic medicine. Tracey, Feinstein’s president and CEO and the brains behind bioelectronic startup Sanguistat, will share keynote duties with Peder Olofsson, a longtime Feinstein Institute researcher and Wallenberg Academy Fellow at the Karolinska Institutet. The two will headline Key Symposium 2016: Bioelectronic Medicine – Technology Targeting Molecular Mechanisms, presented by the Feinstein Institute, the Royal…


Feinstein joins the LI Bioscience Hub

By GREGORY ZELLER // The Feinstein Institute for Medical Research has joined the ranks of the Long Island Bioscience Hub. The Feinstein Institute, the research wing of the Northwell Health system, becomes the LIBH’s fourth member institution, joining Stony Brook University’s Center for Biotechnology, Cold Spring Harbor Laboratory and Brookhaven National Laboratory. As a partner institution, the Feinstein Institute and its researchers are eligible for funding programs supporting feasibility and proof-of-concept studies. The LIBH, which…


LI’s $330M innovation budget

The state delivered on promises to help move Long Island’s innovation economy forward, with more than $330 million tucked away in various pots of the just-passed 2016-17 budget. The headliner: $50 million to jump-start a $350 million center for bioelectronic medicine based on the pioneering research of Kevin Tracey, director of Northwell Health’s Feinstein Center for Medical Research. Bioelectronics, which uses electrical pulses to stimulate the immune system, has the potential to replace drug therapies for such…


Battelle superstar to head bioelectronics center

Chad Bouton, an expert in decoding the brain waves that have allowed paralyzed patients to move or operate a wheel chair by thought alone, has been named managing director of the Feinstein Institute’s new Center for Bioelectronic Medicine. The $300 million center, planned for the Nassau Hub area in Uniondale, will bring together scientists and medical experts to research and commercialize non-drug treatments for such conditions as rheumatoid arthritis, diabetes, gastric conditions and others, including…


Answering our ‘pent-up need’ for new industry

By JOHN L. KOMINICKI // A proposed $300 million center on bioelectronic research would get a $50 million jolt if Albany follows recommendations made this week by a group of business and government leaders. The group, which includes both country executives, Long Island Association chief Kevin Law and five other members, was formed to suggest ways to spend $550 million in state funding that has been earmarked for “transformative” projects downstate. Topping their list was a…


With VNS, additional strides in controlling epilepsy

By GREGORY ZELLER // Dr. Ashesh Mehta, head of North Shore-LIJ’s epilepsy care center, performed two surgeries on July 24, one fairly routine, one a bit less so. For now, anyway. Both involved VNS, or electrical stimulation of the vagus nerves, the long bundle of fibers connecting the brain and abdomen. The first replaced the battery in an existing vagus-stimulation device implanted in a 30-year-old woman. As surgical procedures go, pure housekeeping, Mehta noted. “After…


Feinstein, Battelle partner on ‘Neural Tourniquet’

North Shore-LIJ’s Feinstein Institute is partnering with Ohio health giant Battelle on a so-called Neural Tourniquet that will reshape the way doctors staunch blood loss, from the battlefield to the operating room. The technology is an outgrowth of research pioneered by Feinstein director Kevin Tracey, whose discoveries have helped fuel the bioelectronic medicine field, which combines molecular medicine, bioengineering and neuroscience to develop nerve-stimulating and sensing technologies to regulate biological processes. Tracey’s discoveries have already…


Feinstein eyes $400M center for bioelectronic med

By GREGORY ZELLER // Hundreds of millions of dollars, 250,000 square feet, dozens of laboratories and one throbbing center at the heart of a reinvigorated Long Island economy. Yep. Kevin Tracey thinks big. His vision for a sparkling new Center for Bioelectric Medicine is barely past the drawing board, but already the president and CEO of the Feinstein Institute for Medical Research – the R&D arm of the North Shore-LIJ Health System – envisions a…


SetPoint Medical

Feinstein’s vagus research takes plenty of nerve

BY GREGORY ZELLER // What happens in vagus doesn’t actually stay there. Or at least that’s the theory behind electrical stimulation of the vagus nerve, a long cranial bundle that extends from the brain to the abdomen. Medical science is just scratching the surface of the therapeutic value of vagus stimulation, but new studies suggest it goes far beyond the treatment of certain forms of epilepsy and depression, two longstanding targets of vagus manipulation. Dr….